Table 2.
Univariate Analysis | Odds Ratio | 95%CI |
---|---|---|
Intra-tumoral heterogeneity | 0.19 | 0.02–1.61 |
Multifocality | 0 | |
Midline shift | 2.75 | 0.75–10.11 |
Sinus invasion | 0.62 | 0.12–3.30 |
Necrosis Hemorrhage | 2.71 | 0.78–9.38 |
Mass effect | 4.67 | 0.54–40.11 |
Cystic component† | 21.74 | 3.79–124.54 |
Bone invasion | 2.12 | 0.64–7.08 |
Hyperostosis | 2.04 | 0.60–6.91 |
Spiculation | 1.18 | 0.31–4.45 |
Edema | 1.18 | 0.31–4.45 |
High cluster prominence * | 3.79 | 0.93–15.47 |
Multivariate Analysis | Hazard Ratio | 95%CI |
Cystic component † | 20.21 | 2.46–166.02 |
High cluster prominence †,* | 5.89 | 1.03–33.73 |
* cluster prominence more than 91,000, † p < 0.05, CI—confidence interval.